Ovid Therapeutics Inc. Common Stock (OVID) News

Latest headlines that mention OVID, newest first · each headline opens the original publisher

OVID quote

Last price: $2.54
Day change: -0.78%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

OVID headlines

latest coverage

Not much coverage yet. OVID has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Yahoo Finance 1mo ago

Ovid Therapeutics (OVID) Cashes In One Bet To Fund Its Next Two

General T2OVID

Investing.com 1mo ago

H.C. Wainwright raises Ovid Therapeutics price target to $5 on pipeline progress

General T3OVID

Seeking Alpha 2mo ago

Ovid Therapeutics GAAP EPS of -$0.08 beats by $0.04, revenue of $73M

Earnings T2OVID

Yahoo Finance 3mo ago

Ovid Therapeutics (OVID) Appoints Kevin Norrett as Chief Business Officer

General T2OVID

Seeking Alpha News 3mo ago

Ovid Therapeutics: Risk-Adjusted Valuation Shows Deep Discount Despite 700% Rally

Markets T2OVID

Seeking Alpha News 3mo ago

Ovid Therapeutics: Buy Next-Gen GABA-Aminotransferase Inhibitor OV329 And TSC/IS Expansions

General T2OVID

Seeking Alpha 5mo ago

Ovid Therapeutics GAAP EPS of -$0.12 in-line

Earnings T2OVID

OVID news alerts

Get an alert by email or push when a new headline mentions OVID.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.